These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 18318438)

  • 1. Activation of liver X receptor sensitizes mice to gallbladder cholesterol crystallization.
    Uppal H; Zhai Y; Gangopadhyay A; Khadem S; Ren S; Moser JA; Xie W
    Hepatology; 2008 Apr; 47(4):1331-42. PubMed ID: 18318438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The G protein-coupled receptor G2A: involvement in hepatic lipid metabolism and gallstone formation in mice.
    Johnson LE; Elias MS; Bolick DT; Skaflen MD; Green RM; Hedrick CC
    Hepatology; 2008 Oct; 48(4):1138-48. PubMed ID: 18821587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAV1 Prevents Gallbladder Cholesterol Crystallization by Regulating Biosynthesis and Transport of Bile Salts.
    Xu G; Li Y; Jiang X; Chen H
    J Cell Biochem; 2016 Sep; 117(9):2118-27. PubMed ID: 26875794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts.
    He J; Nishida S; Xu M; Makishima M; Xie W
    Gastroenterology; 2011 Jun; 140(7):2095-106. PubMed ID: 21354151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Constitutive Androstane Receptor Prevents Cholesterol Gallstone Formation.
    Cheng S; Zou M; Liu Q; Kuang J; Shen J; Pu S; Chen L; Li H; Wu T; Li R; Li Y; Jiang W; Zhang Z; He J
    Am J Pathol; 2017 Apr; 187(4):808-818. PubMed ID: 28283178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezetimibe prevents cholesterol gallstone formation in mice.
    Zúñiga S; Molina H; Azocar L; Amigo L; Nervi F; Pimentel F; Jarufe N; Arrese M; Lammert F; Miquel JF
    Liver Int; 2008 Aug; 28(7):935-47. PubMed ID: 18783541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones.
    Wang HH; Portincasa P; Mendez-Sanchez N; Uribe M; Wang DQ
    Gastroenterology; 2008 Jun; 134(7):2101-10. PubMed ID: 18442485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperine prevents cholesterol gallstones formation in mice.
    Song XY; Xu S; Hu JF; Tang J; Chu SF; Liu H; Han N; Li JW; Zhang DM; Li YT; Chen NH
    Eur J Pharmacol; 2015 Mar; 751():112-7. PubMed ID: 25645812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear receptors and cholesterol metabolism in the intestine.
    Moschetta A
    Atheroscler Suppl; 2015 Feb; 17():9-11. PubMed ID: 25659870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.
    Wang HH; Portincasa P; Wang DQ
    Eur J Clin Invest; 2016 Feb; 46(2):158-69. PubMed ID: 26683129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of hepatic microsomal triglyceride transfer protein protects mice from diet-induced gallstones.
    Amigo L; Castro J; Miquel JF; Zanlungo S; Young S; Nervi F
    Gastroenterology; 2006 Dec; 131(6):1870-8. PubMed ID: 17064699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ezetimibe prevents the formation of oestrogen-induced cholesterol gallstones in mice.
    de Bari O; Wang HH; Portincasa P; Paik CN; Liu M; Wang DQ
    Eur J Clin Invest; 2014 Dec; 44(12):1159-68. PubMed ID: 25303682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic overexpression of Niemann-Pick C2 protein promotes cholesterol gallstone formation in mice.
    Acuña M; González-Hódar L; Amigo L; Castro J; Morales MG; Cancino GI; Groen AK; Young J; Miquel JF; Zanlungo S
    J Hepatol; 2016 Feb; 64(2):361-369. PubMed ID: 26453970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of Niemann-Pick C1 protein protects against diet-induced gallstone formation in mice.
    Morales MG; Amigo L; Balboa E; Acuña M; Castro J; Molina H; Miquel JF; Nervi F; Rigotti A; Zanlungo S
    Liver Int; 2010 Jul; 30(6):887-97. PubMed ID: 20408952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ezetimibe ameliorates cholecystosteatosis.
    Mathur A; Walker JJ; Al-Azzawi HH; Lu D; Swartz-Basile DA; Nakeeb A; Pitt HA
    Surgery; 2007 Aug; 142(2):228-33. PubMed ID: 17689690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone prevents cholesterol gallstone formation through the regulation of cholesterol homeostasis in guinea pigs with a lithogenic diet.
    Han T; Lv Y; Wang S; Hu T; Hong H; Fu Z
    Lipids Health Dis; 2019 Dec; 18(1):218. PubMed ID: 31829191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of curcumin and piperine prevents formation of gallstones in C57BL6 mice fed on lithogenic diet: whether NPC1L1/SREBP2 participates in this process?
    Li Y; Li M; Wu S; Tian Y
    Lipids Health Dis; 2015 Sep; 14():100. PubMed ID: 26335572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide 1 analogue prevents cholesterol gallstone formation by modulating intestinal farnesoid X receptor activity.
    Zhang Z; Du Z; Liu Q; Wu T; Tang Q; Zhang J; Huang C; Huang Y; Li R; Li Y; Zhao Y; Zhang G; Zhou J; Huang H; Fang Z; He J
    Metabolism; 2021 May; 118():154728. PubMed ID: 33581130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of cholesterol gallstone disease by schaftoside in lithogenic diet-induced C57BL/6 mouse model.
    Liu M; Liu C; Chen H; Huang X; Zeng X; Zhou J; Mi S
    Eur J Pharmacol; 2017 Nov; 815():1-9. PubMed ID: 28993159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothyroidism Increases Cholesterol Gallstone Prevalence in Mice by Elevated Hydrophobicity of Primary Bile Acids.
    Kube I; Tardio LB; Hofmann U; Ghallab A; Hengstler JG; Führer D; Zwanziger D
    Thyroid; 2021 Jun; 31(6):973-984. PubMed ID: 33231505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.